RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 104 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $53,000 | -39.1% | 22,439 | -42.7% | 0.00% | -50.0% |
| Q2 2016 | $87,000 | +210.7% | 39,160 | +190.3% | 0.00% | +100.0% |
| Q1 2016 | $28,000 | -78.0% | 13,490 | -67.9% | 0.00% | -50.0% |
| Q4 2015 | $127,000 | -32.4% | 42,021 | -44.9% | 0.00% | -33.3% |
| Q3 2015 | $188,000 | +118.6% | 76,300 | +216.6% | 0.00% | +50.0% |
| Q1 2015 | $86,000 | +68.6% | 24,100 | +7.8% | 0.00% | +100.0% |
| Q4 2014 | $51,000 | +41.7% | 22,346 | +21.6% | 0.00% | 0.0% |
| Q3 2014 | $36,000 | -81.7% | 18,378 | -66.3% | 0.00% | -66.7% |
| Q2 2014 | $197,000 | +50.4% | 54,475 | +61.5% | 0.00% | +50.0% |
| Q1 2014 | $131,000 | +59.8% | 33,728 | +16.1% | 0.00% | +100.0% |
| Q4 2013 | $82,000 | -34.4% | 29,049 | -16.9% | 0.00% | -50.0% |
| Q3 2013 | $125,000 | – | 34,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |